A Phase 1b/2, Open-Label, Multicenter, Dose Escalation And Dose Expansion Study Of Nktr-255 InCombination With Cetuximab As A Salvage Regimen For Solid Tumors

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.